Vita Reed covers healthcare, including health insurance, hospitals, medical devices and drug companies for the Orange County Business Journal. She can be reached at firstname.lastname@example.org.
Mission Hospital said that it is opening a new $185 million Neuroscience and Spine Institute tomorrow on its main Mission Viejo campus.
Aliso Viejo-based Avanir Pharmaceuticals Inc.’s shares rose today on positive clinical trial results for a potential Alzheimer’s disease treatment.
Allergan Inc. said today that a federal judge has set an Oct. 28 hearing for a preliminary injunction against hostile suitors Valeant Pharmaceuticals International Inc. and activist investor Bill Ackman’s Pershing Square Capital Management LP.
Irvine-based Allergan Inc. has filed papers with state officials saying it will lay off 129 employees.
Laguna Hills-based Sonendo Inc. said it completed a $35 million round of equity financing.
Edwards, Endologix Among Big Gainers on Consultant List
Irvine-based medical device makers Edwards Lifesciences Corp. and Endologix Inc. are vastly different when it comes to revenue and profit, but they both rank among the top 10 hirers in the medical technology field over the past five years, according to a recently released report.
34 Companies Employed 16,000+ in Orange County
The 34 largest medical device makers in Orange County experienced 2% job growth during the 12 months ended in August, according to the Business Journal’s annual list.
St. Joseph Hoag Sets Up at Irvine Company Complex
St. Joseph Hoag Health’s latest building block for the integrated regional care delivery it aims to establish throughout Orange County is the cornerstone of the Irvine Company’s newest idea to bolster the amenities at a couple of its bigger apartment complexes.
Allergan Leads the Way With 2,400 Local Workers
Irvine-based Allergan Inc. is the runaway leader on the Business Journal’s annual list of drugmakers based in Orange County or with sizable local operations.
Device Maker Seeks FDA Approval, Builds US Sales Force
AcuFocus Inc. is banking on a recent cash infusion and a tiny device implanted in the eye to spur big growth.